Abstract: A method is disclosed for tailoring an activation state of a protocol data unit session between a test network and at least one user equipment. A test system for testing a wireless connection between at least one user equipment and a test network is also provided. The user equipment is registered with the test network. The protocol data unit session is established between the test network and the user equipment. The protocol data unit session between the test network and the user equipment is resumed after at least one radio resource control connection of the protocol data unit session between the test network and the user equipment was released once a release condition was met. The resuming is based on a resuming signal provided by a control device coupled to the test network such that an activation state of the protocol data unit session is modifiable.

Abstract: A void occlusion implant (10) for inserting into a void in a body tissue, the implant (10) comprises a polymeric material which is capable of transitioning from a compressed state to an expanded state upon exposure to a stimulus, wherein in the expanded state the implant is capable of assuming the size and shape of the void and wherein the implant (10) exhibits a peak expansion force of 0.1 to 2N at 37° C.

Abstract: The invention relates to a method of enhancing the solubility and/or the rate of dissolution of a Class II or Class IV low solubility molecule, a method of producing a spray-dried composition, and a spray-dried composition comprising a Class II or Class IV low solubility molecule, albumin and an agent that prevents self-aggregation of albumin.

Abstract: A multi-game ticket assembly and associated method of making include a substrate having a front surface and a back surface. A first game play area is provided on the front surface and includes a plurality of game symbols for play of a first game. A second game play area is provided on the back surface and includes one or more windows defined therein for play of a second game partially embodied on the back surface. A fold line indication on the front surface and divides the substrate into a first portion and a second portion. The second portion is foldable onto the first portion in a folded state of the substrate such that the front surface of the second portion is against the front surface of the first portion and the one or more windows align with the first game play area. The game symbols in the first game play area that are visible to a player through the one or more windows in the folded state of the substrate determine an outcome of the second game.

Abstract: A pharmaceutical formulation comprising a solid matrix of one or more biodegradable polymers, the solid matrix including a pharmaceutically active substance or a pharmaceutically acceptable salt thereof distributed homogeneously or substantially homogeneously within the matrix; wherein the pharmaceutically active substance is, for example, a gonadotropin releasing hormone (GnRH), a GnRH agonist or a GnRH antagonist.

Abstract: According to an embodiment of the present invention, a computer implemented method and system for determining an optimization schedule comprising: executing, via the computer processor, a volume forecast determination for at least one ATM device to generate forecast data, wherein the volume forecast comprises a withdrawal forecast and a deposit forecast; executing, via the computer processor, a simulation based on the forecast data to develop a set of possible schedules for the at least one ATM, wherein the simulation considers one or more identified uncertainties; automatically, via the computer processor, generating one or more fault risks based at least in part on the one or more identified uncertainties; and automatically, via the computer processor, determining an optimal schedule for the at least one ATM device based on the one or more fault risks.

Abstract: There is provided a supercritical fluid-based process for preparing a solid polymer matrix containing a core material, wherein the process includes the step of mixing the polymer, core material and supercritical fluid in a mixing vessel, followed at least one cycle of, without recovering the solid polymer matrix, (i) converting the supercritical fluid in the mixing vessel to a sub-critical state, and then (ii) returning the fluid to the supercritical state, provided that the core material does not comprise any of gonadotropin releasing hormone (GnRH), a GnRH agonist and a GnRH antagonist.

Abstract: A pharmaceutical formulation comprising a solid matrix of one or more biodegradable polymers, the solid matrix including a pharmaceutically active substance or a pharmaceutically acceptable salt thereof distributed homogeneously or substantially homogeneously within the matrix; wherein the pharmaceutically active substance is, for example, a gonadotropin releasing hormone (GnRH), a GnRH agonist or a GnRH antagonist.

Abstract: A process for preparing microparticles comprising a biologically active material and a polymer and having a mean particle size expressed as the volume mean diameter (VMD) of from 10 to 500 ?m, wherein the biologically active material is substantially insoluble in the polymer, which process comprises: a. contacting a mixture of the biologically active material or a precursor thereof, the polymer or a precursor thereof and a processing aid with a supercritical fluid which is capable of swelling the polymer under temperature and pressure conditions necessary to maintain the fluid in a supercritical state; b. allowing the supercritical fluid to penetrate and liquefy the polymer, whilst maintaining the temperature and pressure conditions so that the fluid is maintained in a supercritical state; c. releasing the pressure to precipitate microparticles comprising the biologically active agent and the polymer.

Abstract: A process for preparing microparticles comprising a biologically active material and a polymer and having a mean particle size expressed as the volume mean diameter (VMD) of from 10 to 500 ?m, wherein the biologically active material is substantially insoluble in the polymer, which process comprises: a. contacting a mixture of the biologically active material or a precursor thereof, the polymer or a precursor thereof and a processing aid with a supercritical fluid which is capable of swelling the polymer under temperature and pressure conditions necessary to maintain the fluid in a supercritical state; b. allowing the supercritical fluid to penetrate and liquefy the polymer, while maintaining the temperature and pressure conditions so that the fluid is maintained in a supercritical state; c. releasing the pressure to precipitate microparticles comprising the biologically active agent and the polymer.

Abstract: The invention provides a composition comprising (i) a somatotrophic hormone; (ii) a biodegradable polymer component; and (iii) a release modifier. A process for preparing, and the use of such a composition are also provided.

Abstract: A process for preparing microparticles comprising a biologically active material and a polymer and having a mean particle size expressed as the volume mean diameter (VMD) of from 10 to 500 ?m, wherein the biologically active material is substantially insoluble in the polymer, which process comprises: a. contacting a mixture of the biologically active material or a precursor thereof, the polymer or a precursor thereof and a processing aid with a supercritical fluid which is capable of swelling the polymer under temperature and pressure conditions necessary to maintain the fluid in a supercritical state; b. allowing the supercritical fluid to penetrate and liquefy the polymer, whilst maintaining the temperature and pressure conditions so that the fluid is maintained in a supercritical state; c. releasing the pressure to precipitate microparticles comprising the biologically active agent and the polymer.

Abstract: A network controller having a multiprotocol bus interface adapter coupled between a communication network and a computer bus, the adapter including a predictive time base generator; and a management bus controller adapted to monitor and manage preselected components coupled with one of the communication network and the computer bus. The management bus controller is adapted to employ an Alert Standard Format (ASF) specification protocol, a System Management Bus (SMBus) specification protocol, an Intelligent Platform Management Interface (IPMI) specification protocol, a Simple Network Management Protocol (SNMP), or a combination thereof. The network controller also includes a 10/100/1000BASE-T IEEE Std. 802.

Abstract: A process, and structure, used to monitor and control the level of photoresist removed at the periphery of a photoresist coated, semiconductor substrate, has been developed. A monitoring structure comprised of a group of graduated scribe marks, laser formed near the periphery of the semiconductor, monitoring substrate, is included with product semiconductor substrates, during the application of a photoresist layer, and during the photoresist edge bead removal procedure. The width of the photoresist edge bead, removed from product semiconductor substrates is determined via examination of the monitoring semiconductor substrate, in terms of measuring the level of graduated scribe marks, now exposed. This measurement determines the status of the product semiconductor substrates, in regards to continued processing, or rework.